Monogram Orthopaedics Inc. (MGRM) Statistics & Valuation Metrics - Stocknear

Monogram Orthopaedics Inc...

NASDAQ: MGRM · Real-Time Price · USD
6.11
0.18 (3.04%)
At close: Oct 03, 2025, 3:59 PM
6.08
-0.49%
Pre-market: Oct 06, 2025, 07:09 AM EDT

Monogram Orthopaedics Statistics

Share Statistics

Monogram Orthopaedics has 40.59M shares outstanding. The number of shares has increased by 18.29% in one year.

40.59M
18.29%
13.73%
5.64%
18.47M
150
0.04%

Short Selling Information

The latest short interest is 161.43K, so 0.45% of the outstanding shares have been sold short.

161.43K
0.45%
0.57%
1.66

Valuation Ratios

The PE ratio is -4.73 and the forward PE ratio is -74.12. Monogram Orthopaedics's PEG ratio is 0.26.

-4.73
-74.12
0
18.5
5.32
-5.49
0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Monogram Orthopaedics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 10.57, with a Debt / Equity ratio of 0.03.

10.57
10.38
0.03
-0.02
-0.03
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-604.74K
27
0
1.49

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 163.36% in the last 52 weeks. The beta is 0.69, so Monogram Orthopaedics's price volatility has been higher than the market average.

0.69
163.36%
5.66
3.57
72.13
385,966

Income Statement

n/a
-430K
-15.31M
-16.33M
-15.9M
-16.33M
-0.5
Full Income Statement

Balance Sheet

The company has 15.66M in cash and 364K in debt, giving a net cash position of 15.29M.

15.66M
364K
15.29M
-67.99M
15M
7.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.97M and capital expenditures -84K, giving a free cash flow of -14.05M.

-13.97M
-84K
-14.05M
-0.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MGRM does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MGRM is $5.4, which is -11.6% lower than the current price. The consensus rating is "Strong Buy".

$5.4
-11.6%
Strong Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

12.49
2